Literature DB >> 30516314

Photochemical Conjugation and One-Pot Radiolabelling of Antibodies for Immuno-PET.

Malay Patra1,2, Larissa S Eichenberger1, Gregor Fischer3, Jason P Holland1.   

Abstract

Monoclonal antibodies (mAbs), immunoglobulin fragments, and other proteins are important scaffolds in the development of radiopharmaceuticals for diagnostic immuno-positron emission tomography (immuno-PET) and targeted radioimmunotherapy (RIT). Conventional methods for radiolabelling proteins with metal ions such as 68 Ga, 64 Cu, 89 Zr, and 90 Y require multi-step procedures involving pre-purification, functionalisation with a chelate, and subsequent radiolabelling. Standard coupling chemistries are time-consuming, difficult to automate, and involve synthesis, isolation, and storage of an intermediate, new molecular entity (the conjugated mAb) whose biochemical properties can differ from those of the parent protein. To circumvent these issues, we developed a photoradiochemical approach that uses fast, chemoselective, light-induced protein modification under mild conditions with novel metal-ion-binding chelates derivatised with aryl azide (ArN3 ) groups. Experiments show that one-pot photochemical conjugation and radiolabelling of formulated mAbs can be achieved in <20 min.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Radiochemistry; antibody conjugates; aryl azides; photochemistry; positron emission tomography

Mesh:

Substances:

Year:  2019        PMID: 30516314     DOI: 10.1002/anie.201813287

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  11 in total

1.  Light-Induced Radiosynthesis of 89Zr-DFO-Azepin-Onartuzumab for Imaging the Hepatocyte Growth Factor Receptor.

Authors:  Simon Klingler; Rachael Fay; Jason P Holland
Journal:  J Nucl Med       Date:  2020-01-10       Impact factor: 10.057

Review 2.  Recent Advances in the Development of Tetrazine Ligation Tools for Pretargeted Nuclear Imaging.

Authors:  Rocío García-Vázquez; Umberto Maria Battisti; Matthias M Herth
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-30

3.  ImmunoPET: Concept, Design, and Applications.

Authors:  Weijun Wei; Zachary T Rosenkrans; Jianjun Liu; Gang Huang; Quan-Yong Luo; Weibo Cai
Journal:  Chem Rev       Date:  2020-03-23       Impact factor: 60.622

4.  Simultaneous Photoradiochemical Labeling of Antibodies for Immuno-Positron Emission Tomography.

Authors:  Malay Patra; Simon Klingler; Larissa S Eichenberger; Jason P Holland
Journal:  iScience       Date:  2019-03-07

Review 5.  Current outlook on radionuclide delivery systems: from design consideration to translation into clinics.

Authors:  Oleksii O Peltek; Albert R Muslimov; Mikhail V Zyuzin; Alexander S Timin
Journal:  J Nanobiotechnology       Date:  2019-08-21       Impact factor: 10.435

6.  Microfluidic Preparation of 89Zr-Radiolabelled Proteins by Flow Photochemistry.

Authors:  Daniel F Earley; Amaury Guillou; Dion van der Born; Alex J Poot; Jason P Holland
Journal:  Molecules       Date:  2021-02-02       Impact factor: 4.411

7.  Automated light-induced synthesis of 89Zr-radiolabeled antibodies for immuno-positron emission tomography.

Authors:  Simon Klingler; Jason P Holland
Journal:  Sci Rep       Date:  2022-01-13       Impact factor: 4.379

8.  Photoactivatable bis(thiosemicarbazone) derivatives for copper-64 radiotracer synthesis.

Authors:  Daniel F Earley; Jose Esteban Flores; Amaury Guillou; Jason P Holland
Journal:  Dalton Trans       Date:  2022-03-29       Impact factor: 4.390

9.  Charting the Chemical and Mechanistic Scope of Light-Triggered Protein Ligation.

Authors:  Daniel F Earley; Amaury Guillou; Simon Klingler; Rachael Fay; Melanie Gut; Faustine d'Orchymont; Shamisa Behmaneshfar; Linus Reichert; Jason P Holland
Journal:  JACS Au       Date:  2022-02-08

Review 10.  Recent Advances in Bioorthogonal Click Chemistry for Efficient Synthesis of Radiotracers and Radiopharmaceuticals.

Authors:  Sajid Mushtaq; Seong-Jae Yun; Jongho Jeon
Journal:  Molecules       Date:  2019-10-02       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.